Biotechnology in Asia-Pacific
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology industry had total revenues of $88.2bn in 2016, representing a compound annual growth rate (CAGR) of 5.8% between 2012 and 2016.
- The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $46.4bn, equivalent to 52.6% of the industry's overall value.
- The medical/healthcare segment has been driven by increasing pressure from the aging population in Asia-Pacific, most notably in Japan, where a quarter of the population is aged 65 or over.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Asia-Pacific biotechnology market by value in 2016?
- What will be the size of the Asia-Pacific biotechnology market in 2021?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
